Zobrazeno 1 - 4
of 4
pro vyhledávání: '"556"'
Publikováno v:
Cancer Research. 71:556-556
Sulfatase 2 (Sulf2) is an extracellular enzyme which catalyzes the removal of 6-O-sulfate groups on glucosamine from subregions of the glycosaminoglycan heparin sulfate. Sulf2 action alters the binding of protein ligand growth factors such as VEGF, F
Autor:
E Kowalska, Wenancjusz Domagala, Grzegorz Kurzawski, Ewa Grabowska, Marek Mierzejewski, Zbigniew Szych, Jan Lubinski, Rodney J. Scott, Tadeusz Dȩbniak, Cezary Cybulski, Anna Jakubowska, Janina Suchy, Józef Kładny
Publikováno v:
Cancer Research. 64:1604-1606
Several predispositions to colorectal cancer have been identified, but little is known about genetic susceptibilities to disease in older persons. Colorectal cancer is a risk in Crohn’s disease and is believed to be associated with an inappropriate
Autor:
Jason W. H. Wong, Michael J. Bourke, John E. Pimanda, Mathew A. Sloane, Luke B. Hesson, Robyn L. Ward, Nicholas J. Hawkins
Publikováno v:
Cancer Research. 72:LB-375
Colorectal cancer (CRC) develops from intraepithelial neoplasms known as adenomas. Genomic profiling of these premalignant lesions presents an opportunity to discover molecular changes that can lead to colorectal cancer. Some of the earliest changes
Autor:
Tawana Brady-Watts, Yan Tong, Victoria L. Champion, Thomas F. Imperiale, Celette Sugg Skinner, Jeffrey K. Springston, Susan M. Perkins, Laura J. Myers, Connie Krier, Susan M. Rawl, Netsanet Gebregziabher
Publikováno v:
Cancer Research. 71:1817-1817
BACKGROUND: Colorectal cancer (CRC) will affect more than 142,000 Americans and almost 52,000 will die from this disease this year. Approximately half of these deaths could be prevented if CRC screening were consistently implemented. Both CRC inciden